Silicon redistribution, acid site loss and the formation of a core-shell texture upon steaming SAPO-34 and their impact on catalytic performance in the methanol-to-olefins (MTO) reaction

IBM has received funding from the Engineering and Physical Sciences Research Council (EPSRC, Centre for Doctoral Training in Critical Resource Catalysis, EP/I017008/1) and Scotland's Chemistry departments (ScotCHEM). IBM also received a scholarship from the SCI and Santander. Johnson Matthey is thanked for in-kind contributions and hosting IBM in their R&D labs. ABN gratefully acknowledges support from the EPSRC (grants EP/L017008/1 and EP/R023751/1). The research data supporting this publication can be accessed at: https://doi.org/10.17630/09ddc03e-f121-4e79-9b55-674f64d9c8c4 [62].SAPO-34 is a commercially-implemented silicoaluminophosphate catalyst for selective high yield production of ethene and propene from methanol, but high temperature regeneration in the presence of steam leads to its deactivation. A comprehensive investigation of the effect of prolonged hydrothermal treatment on the structure and properties of SAPO 34 explains the changes in its catalytic methanol-to-olefins (MTO) performance. Microcrystalline powdered SAPO-34 (ca. 3 µm crystals, Al17.1P15.6Si3.3O72) and two batches of larger single crystals of SAPO-34 of different Si concentration (20-100 µm; Al17.3P14.7Si4.0O72 and Al17.7P12.3Si5.9O72 ) were steamed (pH2O = 0.95 atm) at 873–1023 K for up to 240 h. The acidity (NH3-TPD), crystallinity (PXRD), framework cation environment (solid-state 27Al, 29Si and 31P MAS NMR) and porosity were followed for all materials; larger crystals were amenable to single crystal X-ray diffraction, FIB-SEM and synchrotron IR microspectroscopy, including operando study during methanol and dimethyl ether conversions. Some level of steaming improved the lifetime of all SAPO-34 materials in MTO catalysis without affecting their olefin selectivity, although more severe conditions led to the formation of core-shell structures, microporosity loss and eventually at 1023 K, recrystallization to a dense phase. All these irreversible changes occurred faster in crystals with higher Si contents. The initial increase in catalytic lifetime results from an activated reduction in acid site density (Eact = 146(18) kJ mol⁻1), a result of redistribution of Si within the SAPO framework without porosity loss. Operando IR with online product analysis during methanol conversion suggests similar reaction pathways in calcined and steamed crystals, but with greatly reduced methoxy group densities in the latter. The gradual development of optically dark crystal cores upon progressive steaming was shown by FIB-SEM to be due to the formation of regions with meso- and macropores, and these were shown by IR mapping to possess low hydroxyl densities.PostprintPostprintPeer reviewe

Structural mass spectrometry decodes domain interaction and dynamics of the full-length Human Histone Deacetylase 2

Human Histone Deacetylase 2 (HDAC2) belongs to a conserved enzyme superfamily that regulates deacetylation inside cells. HDAC2 is a drug target as it is known to be upregulated in cancers and neurodegenerative disorders. It consists of a globular deacetylase and C-terminus intrinsically-disordered domains [1-3]. To date, there is no full-length structure of HDAC2 available due to the high intrinsic flexibility of its C-terminal domain. The intrinsically-disordered domain, however, is known to be important for the enzymatic function of HDAC2 [1, 4]. Here we combine several structural Mass Spectrometry (MS) methodologies such as denaturing, native, ion mobility and chemical crosslinking, alongside biochemical assays and molecular modelling to study the structure and dynamics of the full-length HDAC2 for the first time. We show that MS can easily dissect heterogeneity inherent within the protein sample and at the same time probe the structural arrangement of the different conformers present. Activity assays combined with data from MS and molecular modelling suggest how the structural dynamics of the C-terminal domain, and its interactions with the catalytic domain, regulate the activity of this enzyme

Estimations of dipolar couplings in multiple-spin systems by solid state NMR

EThOS - Electronic Theses Online ServiceGBUnited Kingdo

Selective internuclear coupling estimation in the solid-state NMR of multiple-spin systems

International audienceno abstrac

Supercycled homonuclear dipolar decoupling sequences in solid-state NMR

We compare the performance of the windowed phase-modulated Lee-Goldburg (wPMLG) and the windowed decoupling using mind boggling optimisation (wDUMBO) sequences at various magic-angle spinning rates and nutation frequencies of the pulses. Additionally, we introduce a supercycled version of wDUMBO and compare its efficiency with that of thenon-supercycled implementation of wDUMBO. The efficiency of the supercycled version of wPMLG, denoted wPMLG-S2, is compared with a new supercycled version of wPMLG that we notate as wPMLC-S3. The interaction between the supercycled homonuclear dipolar decoupling sequences and the sample rotation is analysed using symmetry-basedselection rules

Silicon redistribution, acid site loss and the formation of a core-shell texture upon steaming SAPO-34 and their impact on catalytic performance in the methanol-to-olefins (MTO) reaction

SAPO-34 is a commercially-implemented silicoaluminophosphate catalyst for selective high yield production of ethene and propene from methanol, but high temperature regeneration in the presence of steam leads to its deactivation. A comprehensive investigation of the effect of prolonged hydrothermal treatment on the structure and properties of SAPO 34 explains the changes in its catalytic methanol-to-olefins (MTO) performance. Microcrystalline powdered SAPO-34 (ca. 3 µm crystals, Al17.1P15.6Si3.3O72) and two batches of larger single crystals of SAPO-34 of different Si concentration (20-100 µm; Al17.3P14.7Si4.0O72 and Al17.7P12.3Si5.9O72 ) were steamed (pH2O = 0.95 atm) at 873–1023 K for up to 240 h. The acidity (NH3-TPD), crystallinity (PXRD), framework cation environment (solid-state 27Al, 29Si and 31P MAS NMR) and porosity were followed for all materials; larger crystals were amenable to single crystal X-ray diffraction, FIB-SEM and synchrotron IR microspectroscopy, including operando study during methanol and dimethyl ether conversions. Some level of steaming improved the lifetime of all SAPO-34 materials in MTO catalysis without affecting their olefin selectivity, although more severe conditions led to the formation of core-shell structures, microporosity loss and eventually at 1023 K, recrystallization to a dense phase. All these irreversible changes occurred faster in crystals with higher Si contents. The initial increase in catalytic lifetime results from an activated reduction in acid site density (Eact = 146(18) kJ mol⁻1), a result of redistribution of Si within the SAPO framework without porosity loss. Operando IR with online product analysis during methanol conversion suggests similar reaction pathways in calcined and steamed crystals, but with greatly reduced methoxy group densities in the latter. The gradual development of optically dark crystal cores upon progressive steaming was shown by FIB-SEM to be due to the formation of regions with meso- and macropores, and these were shown by IR mapping to possess low hydroxyl densities

CSD 2039327 & 2039328: Experimental Crystal Structure Determination

Related Article: Ivalina B. Minova, Nathan S. Barrow, Andrea C. Sauerwein, Aaron B. Naden, David B. Cordes, Alexandra M.Z. Slawin, Stephen J. Schuyten, Paul A. Wright|2021|J.Catalysis|395|425|doi:10.1016/j.jcat.2021.01.01

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity

Contains fulltext : 118242.pdf (publisher's version ) (Open Access)BACKGROUND: Gene-based vaccination using prime/boost regimens protects animals and humans against malaria, inducing cell-mediated responses that in animal models target liver stage malaria parasites. We tested a DNA prime/adenovirus boost malaria vaccine in a Phase 1 clinical trial with controlled human malaria infection. METHODOLOGY/PRINCIPAL FINDINGS: The vaccine regimen was three monthly doses of two DNA plasmids (DNA) followed four months later by a single boost with two non-replicating human serotype 5 adenovirus vectors (Ad). The constructs encoded genes expressing P. falciparum circumsporozoite protein (CSP) and apical membrane antigen-1 (AMA1). The regimen was safe and well-tolerated, with mostly mild adverse events that occurred at the site of injection. Only one AE (diarrhea), possibly related to immunization, was severe (Grade 3), preventing daily activities. Four weeks after the Ad boost, 15 study subjects were challenged with P. falciparum sporozoites by mosquito bite, and four (27%) were sterilely protected. Antibody responses by ELISA rose after Ad boost but were low (CSP geometric mean titer 210, range 44-817; AMA1 geometric mean micrograms/milliliter 11.9, range 1.5-102) and were not associated with protection. Ex vivo IFN-gamma ELISpot responses after Ad boost were modest (CSP geometric mean spot forming cells/million peripheral blood mononuclear cells 86, range 13-408; AMA1 348, range 88-1270) and were highest in three protected subjects. ELISpot responses to AMA1 were significantly associated with protection (p = 0.019). Flow cytometry identified predominant IFN-gamma mono-secreting CD8+ T cell responses in three protected subjects. No subjects with high pre-existing anti-Ad5 neutralizing antibodies were protected but the association was not statistically significant. SIGNIFICANCE: The DNA/Ad regimen provided the highest sterile immunity achieved against malaria following immunization with a gene-based subunit vaccine (27%). Protection was associated with cell-mediated immunity to AMA1, with CSP probably contributing. Substituting a low seroprevalence vector for Ad5 and supplementing CSP/AMA1 with additional antigens may improve protection. TRIAL REGISTRATION: ClinicalTrials.govNCT00870987